(D) 8 of the members shall be individuals 
representative of substance abuse treatment 
and recovery experts, including medical doctors, 
licensed addiction therapists, and scientific and 
academic researchers, of which 1 individual may 
be a representative of a local or State govern-
ment agency that oversees or coordinates pro-
grams that address substance use disorder. 
(2) CHAIR.—From the members appointed 
under paragraph (1), the Secretary of Labor shall 
appoint a chairperson. 
(3) TERMS.—Each member of the Advisory 
Committee shall serve for a term of three years. A 
member appointed to fill a vacancy shall be ap-
pointed only for the remainder of such term. 
(4) QUORUM.—A majority of members of the 
Advisory Committee shall constitute a quorum and 
action shall be taken only by a majority vote of the 
members. 
(5) VOTING.—The Advisory Committee shall es-
tablish voting procedures. 
(6) NO COMPENSATION.—Members of the Advi-
sory Committee shall serve without compensation. 
VerDate Sep 11 2014 
18:34 Jun 04, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5892.IH
H5892
pbinns on DSK79D2C42PROD with BILLS
(7) DISCLOSURE.—Every member of the Advi-
sory Committee must disclose the entity, if applica-
ble, that he or she is representing. 
(c) DUTIES.— 
(1) ADVISEMENT.— 
(A) IN
GENERAL.—The Advisory Com-
mittee established under subsection (a) shall 
advise the Secretary of Labor on actions the 
Department of Labor can take to provide infor-
mational resources and best practices on how to 
appropriately address the impact of opioid 
abuse on the workplace and support workers 
abusing opioids. 
(B) CONSIDERATIONS.—In providing such 
advice, the Advisory Committee shall take into 
account— 
(i) evidence-based and other employer 
substance abuse policies and best practices 
regarding opioid use or abuse, including 
benefits provided by employee assistance 
programs or other employer-provided bene-
fits, programs, or resources; 
(ii) the effect of opioid use or abuse 
on the safety of the workplace as well as 
VerDate Sep 11 2014 
18:34 Jun 04, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5892.IH
H5892
pbinns on DSK79D2C42PROD with BILLS
policies and procedures addressing work-
place safety and health; 
(iii) the impact of opioid abuse on 
productivity and absenteeism, and assess-
ments of model human resources policies 
that support workers abusing opioids, such 
as policies that facilitate seeking and re-
ceiving treatment and returning to work; 
(iv) the extent to which alternative 
pain management treatments other than 
opioids are or should be covered by em-
ployer-sponsored health plans; 
(v) the legal requirements protecting 
employee privacy and health information in 
the workplace, as well as the legal require-
ments related to nondiscrimination; 
(vi) potential interactions of opioid 
abuse with other substance use disorders; 
(vii) any additional benefits or re-
sources available to an employee abusing 
opioids that promote retaining employment 
or reentering the workforce; 
(viii) evidence-based initiatives that 
engage employers, employees, and commu-
nity leaders to promote early identification 
VerDate Sep 11 2014 
18:34 Jun 04, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5892.IH
H5892
pbinns on DSK79D2C42PROD with BILLS
of opioid abuse, intervention, treatment, 
and recovery; 
(ix) 
workplace 
policies 
regarding 
opioid abuse that reduce stigmatization 
among fellow employees and management; 
and 
(x) the legal requirements of the Men-
tal Health Parity and Addiction Equity 
Act and other laws related to health cov-
erage of substance abuse and mental 
health services and medications. 
(2) REPORT.—Prior to its termination as pro-
vided in subsection (j), the Advisory Committee shall 
issue a report to the Secretary of Labor and to the 
Committee on Education and the Workforce of the 
House of Representatives and the Committee on 
Health, Education, Labor, and Pensions of the Sen-
ate, detailing successful programs and policies in-
volving workplace resources and benefits, including 
recommendations or examples of best practices for 
how employers can support and respond to employ-
ees impacted by opioid abuse. 
(d) MEETINGS.—The Advisory Committee shall meet 
at least twice a year at the call of the chairperson. 
VerDate Sep 11 2014 
18:34 Jun 04, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5892.IH
H5892
pbinns on DSK79D2C42PROD with BILLS
(e) STAFF SUPPORT.—The Secretary of Labor shall 
make available staff necessary for the Advisory Committee 
to carry out its responsibilities. 
(f) FEDERAL
ADVISORY
COMMITTEE
ACT.—The 
Federal Advisory Committee Act shall apply to the Advi-
sory Committee established under this Act. 
(g) NO
APPROPRIATED
FUNDS.—No additional 
funds are authorized to be appropriated to carry out this 
Act. Expenses of the Advisory Committee shall be paid 
with funds otherwise appropriated to Departmental Man-
agement within the Department of Labor. 
(h) EX OFFICIO.—Three nonvoting representatives 
from agencies within the Department of Health and 
Human Services whose responsibilities include opioid pre-
scribing guidelines, workplace safety, and monitoring of 
substance abuse and prevention programs shall be ap-
pointed by the Secretary of Labor and designated as ex 
officio members. 
(i) AGENDA.—The Secretary of Labor or a represent-
ative of the Secretary shall consult with the Chair in es-
tablishing the agenda for Committee meetings. 
(j) TERMINATION.—The Advisory Committee estab-
lished under this Act shall terminate three years after the 
date of enactment of this Act. 
Æ 
VerDate Sep 11 2014 
18:34 Jun 04, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\H5892.IH
H5892
pbinns on DSK79D2C42PROD with BILLS